West Virginia Attorney General Patrick Morrisey said the state will receive more than $153,000 in a national settlement with a prescription drug manufacturer.
Morrisey says in a news release last month that every state and the District of Columbia are participating in the $13.5 million settlement with Boehringer Ingelheim Pharmaceuticals Inc.
The settlement resolves allegations that the company misrepresented the effectiveness of four drugs in treating or managing certain health conditions, including heart attacks, congestive heart failure and chronic obstructive pulmonary disease. The drugs are Micardis, Aggrenox, Atrovent and Combivent.
Topics Virginia
Was this article valuable?
Here are more articles you may enjoy.
PwC Confirms Cybersecurity Incident Involving Employee Learning Records 
World’s Largest Retirement Community Set to Borrow $180 Million for More Homes 
Florida Reforms Cut Property Premiums but Data Show Multifamily Liability Rates Up 
PHP Security Flaws Highlight Potential Systemic Risk Aggregation for Cyber Insurers 
